2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92542°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...

¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...
³×¿ÀÆÊ ¡®¾ÆÅäÆÊ MLE Å©¸²¡¯ ¾Æ¸¶Á¸ ÇÁ¶óÀÓµ¥ÀÌ ¸ÅÃâ »ó½Â µ¹Ç³ (2025-07-26)
iM¹ðÅ©, Çѱ¹¾¾Æ¼ÀºÇà °í°´ Àüȯ ¾÷¹«Çù¾à ü°á (2025-07-30)
Çö´ëÂ÷, '¾ÆÀÌ¿À´Ð 9 ¾¾µåº¼ µå·Ð ½ºÅ×À̼Ç' ±¸Ãà (2025-07-31)
ÈüÇÑ ÃëÇâ, ºÒ±³Äھ ºÒ±³ °¨¼º ±ÂÁºê·£µå (2025-08-07)
Áß±¹, ¾Æ½Ã¾Æ ¸®Ã÷ ½ÃÀå ¼ºÀå ÁÖµµ¡¦ Àεµ ¿ª½Ã °ßÁ¶ÇÑ ¼ºÀå¼¼ (2025-07-30)
'Çѱ¹¹®ÇÐÀÇ ¹Ì·¡°¡ µÉ ÀþÀº ÀÛ°¡¡¯ 1À§¿¡ Á¶¿¹Àº ÀÛ°¡ (2025-07-25)
GS25 ¡®Á¤¼º°¡µæºñºö¹ä¡¯ µµ½Ã¶ô »çÀü ¿¹¾à 1À§ µî±Ø (2025-07-30)
Äɵà¿Ã, AI ±â¹Ý Çѱ¹¾î ÇнÀ Ç÷§Æû º£Æ®³² Çù·Â °¡¼Ó (2025-07-28)
Omdia: Asia¡¯s Game Subscription Market Set to Reach $9.4bn ... (2025-08-07)
¾Æ½Ä½º ¸ÞŸ½ºÇÇµå ½Ã¸®Áî °ø°³ (2025-07-31)
Á¤·Á¿ø, äÁ¤¾È, À±½Â¾Æ µî ¿ÊÀß¾Ë ¼¿·´µéÀÌ ÇÈÇÑ °¡¹æÀº? (2025-07-26)
ÆùŸ³ª, Á¦·Î µå·¹½Ì ¹ß»ç¹Í Ãâ½Ã (2025-08-01)
'¼ººÏ¹®È­¹ÙIJ½º' ¿ì¸®µ¿³× ¿îµ¿ÀåÀÌ ÃÊ´ëÇü ¿öÅÍÆÄÅ©·Î (2025-08-01)
½ºÆ©µð¿Àºñ»çÀ̵å, ÅõÀÚ»ç·ÎºÎÅÍ À繫Àû ÅõÀÚ À¯Ä¡ (2025-07-24)
Andersen Consulting Strengthens Cybersecurity Capabilities w... (2025-08-04)
Takeda Receives FDA 510(k) Clearance for HyHub¢â and HyHub¢â... (2025-08-07)
DTN Launches Industry-First Operational Decisioning Platform... (2025-08-04)
Á¦³×½Ã½º, ¡®¼Ò¼È¾ÆÀ̾î¿öµå 2025¡¯ µðÁöÅпµ»ó ÃÖ°í´ë»ó (2025-08-02)
¡®µ¹½Ì ÇϿ콺¡¯¿¡¼­ÀÇ Ã¹Â° ³¯ ¹ã, Ãæ°ÝÀûÀÎ ÀÌÈ¥ »çÀ¯µé (2025-07-27)
¡®°¶·°½Ã Z Æúµå7¡¤Z Çø³7¡¯ üÇèÁ¸ ÄÚ¿¢½º¿¡ ÆîÄ£´Ù (2025-07-28)
°Ç¼³ÇöÀå µå·Ð µ¥ÀÌÅÍ ¼öÁý¡¤Ã³¸® ¿ÏÀü ÀÚµ¿È­ ½Ã´ë (2025-08-02)
Bureau Veritas Partners with IFC¡¯s Building Resilience Inde... (2025-08-07)
µÎ»ê¿¡³Êºô¸®Æ¼, »ç¿ìµð¼­ 1300¾ï¿ø ±Ô¸ð ¿¬·áÀüȯ °ø»ç ¼öÁÖ (2025-05-12)
¡®ADHD »ç¿ë ¼³¸í¼­¡¯ Ãâ°£ (2025-05-13)
2025 ¡®¼­¿ï¿¹¼ú¿µÀç À½¾Ç±³À°¡¯ »ç¾÷ ¼±¹ß 59¸í ¡æ 70¸í (2025-03-12)
       [ÀÌÀü][1]....[70][71][72][73][74][75][76][77][78]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..